Literature DB >> 7276093

Inhibition of leukocyte locomotion by hyaluronic acid.

J V Forrester, P C Wilkinson.   

Abstract

The effect of hyaluronate on neutrophil motility in vitro was studied by the micropore filter technique and by direct visual analysis of the locomotion of neutrophils on glass. Both directed and random locomotion of neutrophils was inhibited by physiological concentrations (0.5-6.0 mg ml(-1)) of hyaluronate in a dose- and molecular weight-dependent manner. Inhibition of cell movement was more pronounced for high molecular weight chemoattractants such as casein than for small chemotactic peptides such as f-Met-Leu-Phe. Chemotactic factor gradient formation in filter chambers was profoundly retarded by hyaluronate, which may partly explain the inhibitory effects of hyaluronate on directed neutrophil locomotion. In addition, hyaluronate inhibited the binding of chemotactic factor to the neutrophil surface. This effect, together with a reduction in cell-to-substratum adhesion, may provide an additional explanation for hyaluronate-induced inhibition of random neutrophil locomotion. Inhibition of locomotion by hyaluronate was easily reversed by washing the cells free of hyaluronate; thus competition by hyaluronate for cell-surface binding sites is unlikely, and physical effects such as steric exclusion or molecular sieving by the large hyaluronate polymer provide the most probable explanations of its inhibitory effect on cell locomotion. Since hyaluronate is a major constituent of tissue matrices, these results draw attention to the importance of the extracellular environment in regulating inflammatory cell movement in vivo.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7276093     DOI: 10.1242/jcs.48.1.315

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  32 in total

Review 1.  [Intra-articular injection. Substances and techniques].

Authors:  D von Stechow; M Rittmeister
Journal:  Orthopade       Date:  2003-12       Impact factor: 1.087

Review 2.  Hyaluronate in rheumatology and orthopaedics: is there a role?

Authors:  R K Strachan; P Smith; D L Gardner
Journal:  Ann Rheum Dis       Date:  1990-11       Impact factor: 19.103

3.  Intra-articular hyaluronan treatment for osteoarthritis.

Authors:  E George
Journal:  Ann Rheum Dis       Date:  1998-11       Impact factor: 19.103

4.  Hyaluronic acid enhances phagocytosis of human monocytes in vitro.

Authors:  T Ahlgren; C Jarstrand
Journal:  J Clin Immunol       Date:  1984-05       Impact factor: 8.317

5.  Cellular composition of post-haemorrhagic opacities in the human vitreous.

Authors:  J V Forrester; W R Lee
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1981

6.  In vitro effects of hyaluronan on prostaglandin E2 induction by interleukin-1 in rabbit articular chondrocytes.

Authors:  M Akatsuka; Y Yamamoto; K Tobetto; T Yasui; T Ando
Journal:  Agents Actions       Date:  1993-01

7.  Hyaluronidase significantly enhances the efficacy of regional vinblastine chemotherapy of malignant melanoma.

Authors:  T Spruss; G Bernhardt; H Schönenberger; W Schiess
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

Review 8.  Proteoglycans and cell adhesion. Their putative role during tumorigenesis.

Authors:  E A Turley
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

9.  Phacoviscocanalostomy for open-angle glaucoma with concomitant age-related cataract.

Authors:  Alexandros N Stangos; Anestis Mavropoulos; Gordana Sunaric-Megevand
Journal:  Clin Ophthalmol       Date:  2007-12

10.  Production of IGF-II-related peptide by an anaplastic cell line (AT-3) established from the Dunning prostatic carcinoma of rats.

Authors:  Y Matuo; N Nishi; H Tanaka; I Sasaki; J T Isaacs; F Wada
Journal:  In Vitro Cell Dev Biol       Date:  1988-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.